Family Dollar Stye Eye Ointment Recalled Due to Improper Storage
Family Dollar is recalling Stye Eye Ointment 0.125 oz due to manufacturing deviations. The product was held outside appropriate storage temperature conditions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a manufacturing storage deviation that warrants precautionary action but does not indicate acute risk or reported harm.
Plain-English summary
Family Dollar Stores, Llc. is recalling Stye Eye Ointment 0.125 oz distributed to specific Family Dollar Stores from April 30, 2022 through June 10, 2022. The recall results from Current Good Manufacturing Practice (CGMP) deviations: the product was held outside appropriate storage temperature conditions.
The affected product is identified by SKU 998301 and was distributed nationwide within the United States during the specified time period.
The recalled product
- Product
- STYE EYE OINTMENT 0.125 OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Eye Medication
- Hazard
- improper-storage
- temperature-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 998301
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27